A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis (2020)
- Authors:
- USP affiliated authors: CANÇADO, EDUARDO LUIZ RACHID - FM ; FOSSALUZA, VICTOR - IME ; CARRILHO, FLAIR JOSÉ - FM ; ONO, SUZANE KIOKO - FM ; UHRIGSHARDT, GABRIELA GUIMARÃES - IME ; LITING, ZHENG - IME ; NAKANO, LARISSA AKEME - FM ; NABESHIMA, MARIANA AKEMI - FM
- Unidades: FM; IME
- DOI: 10.1186/s12876-020-01399-5
- Subjects: GASTOS EM SAÚDE; ESTATÍSTICA DESCRITIVA; INFERÊNCIA ESTATÍSTICA
- Keywords: Ursodeoxycholic acid; Primary biliary cholangitis; Capsules; Tablets; Health care costs; Hospital
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC Gastroenterology
- ISSN: 1471-230X
- Volume/Número/Paginação/Ano: v. 20, artigo n. 253, p.253-261, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NAKANO, Larissa Akeme et al. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, v. 20, n. artigo 253, p. 253-261, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12876-020-01399-5. Acesso em: 10 fev. 2026. -
APA
Nakano, L. A., Cançado, E. L. R., Chaves, C. E., Madeira, M. C. V., Katayose, J. T., Nabeshima, M. A., et al. (2020). A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, 20( artigo 253), 253-261. doi:10.1186/s12876-020-01399-5 -
NLM
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1186/s12876-020-01399-5 -
Vancouver
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1186/s12876-020-01399-5 - Relatório de análise estatística sobre o projeto "avaliação da eficácia terapêutica entre cápsulas e comprimidos do ácido ursodesoxicólico 300mg no tratamento da colangite biliar"
- A prospective study of hepatitis B virus markers in patients with chronic HBV infection from brazilian families of western and asian origin
- Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis
- Clinical Features of Refractory Ascites in Outpatients
- Assessment of the prevalence of vertical hepatitis B transmission in two consecutive generations
- Nódulos hepáticos: diagnóstico e conduta
- Genetic Risk for Alcoholic Chronic Pancreatitis
- UGT1A1*28 relationship with abnormal total bilirubin levels in chronic hepatitis C patients: Outcomes from a case–control study
- Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil
- Clinical trials profile: Professionals and sites
Informações sobre o DOI: 10.1186/s12876-020-01399-5 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3005204.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
